Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen.

Kiener TK, Premanand B, Kwang J.

Expert Rev Vaccines. 2013 Apr;12(4):357-64. doi: 10.1586/erv.13.18.

PMID:
23560917
2.

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.

Zhang F, Hao C, Zhang S, Li A, Zhang Q, Wu W, Liu L, Li C, Liang M, Li X, Li D.

Virol J. 2014 May 6;11:80. doi: 10.1186/1743-422X-11-80.

3.
4.

Production of EV71 vaccine candidates.

Chong P, Hsieh SY, Liu CC, Chou AH, Chang JY, Wu SC, Liu SJ, Chow YH, Su IJ, Klein M.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1775-83. doi: 10.4161/hv.21739. Epub 2012 Sep 19. Review.

5.

Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71.

Yu Z, Huang Z, Sao C, Huang Y, Zhang F, Ma G, Chen Z, Zeng Z, Qiwen D, Zeng W.

Arch Virol. 2013 May;158(5):1071-7. doi: 10.1007/s00705-012-1589-z. Epub 2013 Jan 1.

PMID:
23275129
6.

Update on the development of enterovirus 71 vaccines.

Kung YA, Hung CT, Liu YC, Shih SR.

Expert Opin Biol Ther. 2014 Oct;14(10):1455-64. doi: 10.1517/14712598.2014.935330. Epub 2014 Jul 3. Review.

PMID:
24989170
7.

Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.

Premanand B, Prabakaran M, Kiener TK, Kwang J.

PLoS One. 2013;8(2):e55536. doi: 10.1371/journal.pone.0055536. Epub 2013 Feb 4.

8.

Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.

Premanand B, Kiener TK, Meng T, Tan YR, Jia Q, Chow VT, Kwang J.

Antiviral Res. 2012 Sep;95(3):311-5. doi: 10.1016/j.antiviral.2012.05.017. Epub 2012 Jun 9.

PMID:
22691220
9.

Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.

Kolpe AB, Kiener TK, Grotenbreg GM, Kwang J.

Virus Res. 2012 Sep;168(1-2):64-72. doi: 10.1016/j.virusres.2012.06.014. Epub 2012 Jun 20.

PMID:
22728446
10.

[Study on adjuvant effect of oral recombinant subunit vaccine formulated with chitosan against human enterovirus 71].

Zhang S, Zhang FS, Li AQ, Liu L, Wu W, Li C, Zhang QF, Liang MF, Li DX.

Bing Du Xue Bao. 2014 May;30(3):221-5. Chinese.

PMID:
25118374
11.

Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2.

Xu XG, Wang ZS, Zhang Q, Li ZC, Ding L, Li W, Wu HY, Chang CD, Lee LH, Tong DW, Liu HJ.

J Virol Methods. 2012 Feb;179(2):359-66. doi: 10.1016/j.jviromet.2011.11.023. Epub 2011 Dec 6.

PMID:
22172969
12.

Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV.

Pérez-Filgueira DM, Resino-Talaván P, Cubillos C, Angulo I, Barderas MG, Barcena J, Escribano JM.

Virology. 2007 Aug 1;364(2):422-30. Epub 2007 Apr 16.

13.

Expression and immunogenicity of novel subunit enterovirus 71 VP1 antigens.

Xu J, Wang S, Gan W, Zhang W, Ju L, Huang Z, Lu S.

Biochem Biophys Res Commun. 2012 Apr 20;420(4):755-61. doi: 10.1016/j.bbrc.2012.03.067. Epub 2012 Mar 17.

PMID:
22450314
14.

Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.

Ch'ng WC, Stanbridge EJ, Ong KC, Wong KT, Yusoff K, Shafee N.

J Med Virol. 2011 Oct;83(10):1783-91. doi: 10.1002/jmv.22198.

PMID:
21837796
15.

Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model.

Munang'andu HM, Fredriksen BN, Mutoloki S, Brudeseth B, Kuo TY, Marjara IS, Dalmo RA, Evensen Ø.

Vaccine. 2012 Jun 8;30(27):4007-16. doi: 10.1016/j.vaccine.2012.04.039. Epub 2012 Apr 23.

PMID:
22537985
16.

Characterization of the enterovirus 71 VP1 protein as a vaccine candidate.

Zhou SL, Ying XL, Han X, Sun XX, Jin Q, Yang F.

J Med Virol. 2015 Feb;87(2):256-62. doi: 10.1002/jmv.24018. Epub 2014 Jul 9.

PMID:
25043151
17.

Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice.

Wang M, Jiang S, Wang Y.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):387-93. doi: 10.1016/j.bbrc.2012.11.035. Epub 2012 Nov 15.

PMID:
23159634
18.

Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection.

Kim YI, Song JH, Kwon BE, Kim HN, Seo MD, Park K, Lee S, Yeo SG, Kweon MN, Ko HJ, Chang SY.

Vaccine. 2015 Nov 27;33(48):6604-10. doi: 10.1016/j.vaccine.2015.10.103. Epub 2015 Oct 31.

PMID:
26529069
19.

Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.

Pallister JA, Klein R, Arkinstall R, Haining J, Long F, White JR, Payne J, Feng YR, Wang LF, Broder CC, Middleton D.

Virol J. 2013 Jul 16;10:237. doi: 10.1186/1743-422X-10-237.

20.

Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection.

Chen HL, Huang JY, Chu TW, Tsai TC, Hung CM, Lin CC, Liu FC, Wang LC, Chen YJ, Lin MF, Chen CM.

Vaccine. 2008 Jun 2;26(23):2882-9. doi: 10.1016/j.vaccine.2008.03.041. Epub 2008 Apr 10.

PMID:
18450335

Supplemental Content

Support Center